NextCure, Inc. — Major Shareholding Notification 2024

Jun 27, 2024

SC 13G 1 nextcure-sc13g_062024.htm SCHEDULE 13G

Field: Rule-Page

Field: /Rule-Page

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934 (Amendment No. )*

NextCure, Inc.
(Name
of Issuer)

| Common
Stock, par value $0.001 per share |
| --- |
| (Title
of Class of Securities) |

| 65343E
108 |
| --- |
| (CUSIP
Number) |

| Michael
Hirschberg, Esq. Reitler
Kailas & Rosenblatt LLP 885
Third Avenue, 20th Floor New
York, NY 10022 |
| --- |
| (Name,
Address and Telephone Number of Person Authorized to Receive Notices and Communications) |

June 20, 2024
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d)

• The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Field: Page; Sequence: 1

Field: /Page

CUSIP No. 65343E 108 13G Page 2 of 7 Pages

| 1. | NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Affinity
Healthcare Fund, LP (EIN 82-1629802) |
| --- | --- |
| 2. | CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ☐ (b) ☐ |
| 3. | SEC USE ONLY |
| 4. | CITIZENSHIP
OR PLACE OF ORGANIZATION Delaware |

| NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | SOLE
VOTING POWER 0 |
| --- | --- |
| 6. | SHARED
VOTING POWER 1,672,839 shares of Common Stock |
| 7. | SOLE
DISPOSITIVE POWER 0 |
| 8. | SHARED
DISPOSITIVE POWER 1,672,839 shares of Common Stock |

| 9. | AGGREGATE AMOUNT
BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,672,839 shares of Common Stock |
| --- | --- |
| 10. | CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) ☐ |
| 11. | PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9) 5.98% |
| 12. | TYPE
OF REPORTING PERSON (see instructions) PN |

Field: Page; Sequence: 2

Field: /Page

CUSIP No. 65343E 108 13G Page 3 of 7 Pages

| 1. | NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Affinity
Asset Advisors, LLC (EIN 82-1567490) |
| --- | --- |
| 2. | CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ☐ (b) ☐ |
| 3. | SEC USE ONLY |
| 4. | CITIZENSHIP
OR PLACE OF ORGANIZATION Delaware |

| NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | SOLE VOTING POWER 0 |
| --- | --- |
| 6. | SHARED
VOTING POWER 1,672,839 shares of Common Stock |
| 7. | SOLE DISPOSITIVE POWER 0 |
| 8. | SHARED
DISPOSITIVE POWER 1,672,839 shares of Common Stock |

| 9. | AGGREGATE AMOUNT
BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,672,839 shares of Common Stock |
| --- | --- |
| 10. | CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) ☐ |
| 11. | PERCENT OF CLASS
REPRESENTED BY AMOUNT IN ROW (9) 5.98% |
| 12. | TYPE
OF REPORTING PERSON (see instructions) IA |

Field: Page; Sequence: 4

Field: /Page

CUSIP No. 65343E 108 13G Page 4 of 7 Pages

Item 1.

| (a) | Name
of Issuer: NextCure, Inc. |
| --- | --- |
| (b) | Address
of Issuer’s Principal Executive Offices: 9000 Virginia Manor Road Suite 200 Beltsville, MD 20705 |

Item 2.

| (a) | Name
of Persons Filing: Affinity
Healthcare Fund, LP Affinity Asset Advisors, LLC |
| --- | --- |
| (b) | Address
of Principal Business Office or, if None, Residence: 767
Third Avenue, 15 th Floor New
York, NY 10017 |
| (c) | Citizenship: Affinity
Healthcare Fund, LP and Affinity Asset Advisors, LLC - Delaware |
| (d) | Title
of Class of Securities: Common
Stock, par value $0.001 per share |
| (e) | CUSIP
Number: 65343E 108 |

Field: Page; Sequence: 5

Field: /Page

CUSIP No. 65343E 108 13G Page 5 of 7 Pages

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

| (a) | ☐ | Broker or dealer registered under
section 15 of the Act (15 U.S.C. 78o). |
| --- | --- | --- |
| (b) | ☐ | Bank as defined in section 3(a)(6) of the Act (15 U.S.C.
78c). |
| (c) | ☐ | Insurance company as defined in section 3(a)(19) of
the Act (15 U.S.C. 78c). |
| (d) | ☐ | Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C. 80a-8). |
| (e) | ☐ | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
| (f) | ☐ | An employee benefit plan or endowment fund in accordance
with §240.13d-1(b)(1)(ii)(F); |
| (g) | ☐ | A parent holding company or control person in accordance
with §240.13d-1(b)(1)(ii)(G); |
| (h) | ☐ | A savings association as defined in Section 3(b) of
the Federal Deposit Insurance Act (12 U.S.C. 1813); |
| (i) | ☐ | A church plan that is excluded from the definition
of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); |
| (j) | ☐ | A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); |
| (k) | ☐ | Group, in accordance with §240.13d-1(b)(1)(ii)(K). |

Field: Page; Sequence: 6

Field: /Page

CUSIP No. 65343E 108 13G Page 6 of 7 Pages

Item 4. Ownership.

Affinity Asset Advisors, LLC (the “Advisor”) is the investment manager of Affinity Healthcare Fund, LP (the “Fund”) and exercises investment discretion with regard to the securities reported herein. As of June 27, 2024, the Fund beneficially owned an aggregate of 1,672,839 shares of Common Stock of the Issuer, or 5.98% of the outstanding shares of Common Stock of the Issuer, and the Advisor may be deemed to be the beneficial owner of such 1,672,839 shares of Common Stock of the Issuer owned by the Fund by virtue of its position as investment manager of the Fund. The Fund and the Advisor have the shared power to vote or to direct the vote and to dispose or direct the disposition of 1,672,839 shares of Common Stock of the Issuer.

The percentage set forth in the preceding paragraph and in Row 11 of the cover page for each reporting person is based on 27,973,289 shares of Common Stock of the Issuer outstanding as of April 30, 2024 as set forth in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 2, 2024.

Item 5. Ownership of Five Percent or Less of a Class.

Not Applicable

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not Applicable

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not Applicable

Item 8. Identification and Classification of Members of the Group.

Not Applicable

Item 9. Notice of Dissolution of Group.

Not Applicable

Item 10. Certification.

By signing below, we certify that, to the best of our knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Field: Page; Sequence: 7

Field: /Page

CUSIP No. 65343E 108 13G Page 7 of 7 Pages

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

| June 27, 2024 Date |
| --- |
| Affinity
Healthcare Fund, LP |
| By:
/s/ Michael Cho Signature AFFINITY
ASSET ADVISORS, LLC By:
/s/ Michael Cho Signature |

Field: Page; Sequence: 8; Options: Last

Field: /Page